Abstract Submission Key Dates
February 1 at 11:59 PM (EST)
Abstract submission deadline
March 14-15 Scientific Program Committee meets to select abstracts
Late March Abstract notification letters sent by email to First Authors regarding selection decisions
April 2 Deadline for submission of updated Late-Breaking Abstracts
Mid April First Authors of Late-Breaking Abstracts are notified of final selection decisions
April 12 at 11:59 PM (EDT) Deadline to withdraw or make changes to an abstract
May 16 at 6:00 PM (EDT) Abstracts released on ASCO.org*
Yes, I remember a start up biotech named Genta that had "presence" at ASCO years ago, they'd even hired a sales force for their much heralded (PR newswire press releases) Genasense, anti-sense compound. Of course a few days before ASCO, the FDA ripped them a new one on their bLA and so their ASCO presence looked more like a wake.
Very similar pattern with Oxiclean. Data mining from studies that fail to meet primary endpoints and a CEO trying to spin it as positive.
Of course Oxiclean hasn't filed any applications with FDA for approval and no suitors appears to be beating a path to their door. A fool and his money are soon parted. Beware of the snake oil salesman.
Anyone find it odd "teragr50" has removed all his posts between March 2012 and July 2011?
Appears that teragr50 is covering his tracks - did you believe his posts?
Perhaps the SEC finally caught up with his insider info and manipulation . . .
Sound Familiar: "Tender Offer!"
Who else can fill in his pump and dumps:
Booth # 24093 Map It
300 Bear Hill Road
Waltham, MA 02451